Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126105951 | 12610595 | 1 | I | 20160722 | 20160801 | 20160801 | EXP | JP-MYLANLABS-2016M1031117 | MYLAN | TAMADA S, BABA S, YOTSUMOTO D, MATSUKATA A, ANDOU M, SAGARA Y, ET AL. A PATIENT WITH OF METASTATIC BREAST CANCER WITH A WELL-CONTROLLED QUALITY OF LIFE USING S-1 THERAPY AS FIRST-LINE CHEMOTHERAPY. [JAPANESE]. GAN-TO-KAGAKU-RYOHO 2011;38(4):635-637. | 0.00 | Y | 0.00000 | 20160801 | OT | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126105951 | 12610595 | 1 | PS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | 80 MG/MM, 2-3 WEEKS ADMINISTRATION AND 1 WEEK REST | U | U | 91540 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126105951 | 12610595 | 1 | Breast cancer metastatic |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126105951 | 12610595 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126105951 | 12610595 | Alopecia | |
126105951 | 12610595 | Nail avulsion | |
126105951 | 12610595 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |